~~<i id='E54300A411'><strike id='E54300A411'><tt id='E54300A411'><pre id='E54300A411'></pre></tt></strike></i>~~

Home» Wikipedia» Wikipedia

Wikipedia

author：fashion 2025-09-27 15:05:37 Page View：6

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： PBM reforms clear House panel
Next article： In Memoriam: Notable people who died in 2023

explore

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Food makers to regulators: Ultra

Foodmakersdon'twantregulatorstofocusonultra-processedfoodswhentheygotoupdatedietaryguidelines.DanKit

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

WATCH: Why do bright lights make us see spots?

Staringatthesunoratbrightlightswillleavebehindaspottyimprintinyourfieldofvision.Here'swhy.MatthewOrr